Phase 1b Study of Weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Amy Kimball, MD
Amgen
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
59 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cbcc Global Research, Inc. at Comprehensive Blood and Cancer Center
Bakersfield, California, United States
- Research Site
Bakersfield, California, United States
- Providence Saint Joseph Medical Center
Burbank, California, United States
- Research Site
Burbank, California, United States
- Compassionate Care Research Group, Inc.
Fountain Valley, California, United States
- Research Site
Fountain Valley, California, United States
- Los Angeles Hematology / Oncology Medical Group
Los Angeles, California, United States
- Research Site
Los Angeles, California, United States
- Research Site
Los Angeles, California, United States
- Research Site
Whittier, California, United States
- Research Site
Aurora, Colorado, United States
- University of Colorado
Aurora, Colorado, United States
- Lombardi Cancer Center, Pediatric Hematology Oncology
Washington D.C., District of Columbia, United States
- Research Site
Washington D.C., District of Columbia, United States
- Florida Cancer Specialists
Fort Myers, Florida, United States
- Research Site
Fort Myers, Florida, United States
- H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida, United States
- Research Site
Tampa, Florida, United States
- Florida Cancer Specialists
West Palm Beach, Florida, United States
- Research Site
West Palm Beach, Florida, United States
- University of Chicago Medical Center
Chicago, Illinois, United States
- Dana Farber Partners Cancer Care
Boston, Massachusetts, United States
- Research Site
Boston, Massachusetts, United States
- Research Site
Ann Arbor, Michigan, United States
- John Theurer Cancer Center at Hackensack University Medical Center
Hackensack, New Jersey, United States
- Research Site
Hackensack, New Jersey, United States
- Clinical Research Alliance
New York, New York, United States
- Memorial Sloan Kettering
New York, New York, United States
- Morton Coleman, Md
New York, New York, United States
- Research Site
New York, New York, United States
- Research Site
New York, New York, United States
- Weill Cornell Medical College
New York, New York, United States
- Research Site
Stony Brook, New York, United States
- Stony Brook University Medical Center
Stony Brook, New York, United States
- Durham Veterans Affairs Medical Center
Durham, North Carolina, United States
- Research Site
Durham, North Carolina, United States
- Research Site
Cincinnati, Ohio, United States
- Sarah Cannon Research Institute
Cincinnati, Ohio, United States
- Bend Memorial Clinic
Bend, Oregon, United States
- Research Site
Bend, Oregon, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2015
- Primary completion
- 28 Oct 2019
- Completion
- 28 Oct 2019
- Last update posted
- 6 Nov 2020
- Registered enrollment
- 107
- Registry id
- NCT02335983
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.